Male breast cancer: How to optimize the diagnosis?

Authors

  • Laíse Alves Ribeiro Universidade de Ribeirão Preto – Ribeirão Preto (SP), Brazil.
  • João Victor Monteiro de Camargo Universidade de Ribeirão Preto – Ribeirão Preto (SP), Brazil.
  • Alexandre Pelícolla Galli Universidade de Ribeirão Preto – Ribeirão Preto (SP), Brazil.
  • Geovana Sousa Resende Universidade de Ribeirão Preto – Ribeirão Preto (SP), Brazil.
  • Daiane Rosa Dantas Santos Universidade de Ribeirão Preto – Ribeirão Preto (SP), Brazil.
  • Carlos Eduardo Nunes Aranha Universidade de Ribeirão Preto – Ribeirão Preto (SP), Brazil.

DOI:

https://doi.org/10.29289/259453942023V33S1077

Keywords:

male breast cancer, early detection of cancer, diagnostic screening programs

Abstract

Objective: Male breast cancer (MaBC) is a rare disease that represents about 1% of all cases of breast cancer (BC) in Brazil.
The scarcity of screening campaigns hinders early diagnosis, directly affecting treatment and prognosis. Therefore, this
study aimed to increase the visibility, among health professionals, for the aforementioned disease, describing how screening
and diagnosis have been performed until now. Methodology: This study is a systematic literature review. Articles indexed
in the electronic databases PubMed, SciELO, and ScienceDirect were collected. Studies were selected using the following
descriptors and keywords: (Breast Cancer) AND (Men). Results: The avoidance of medical services by men, the absence
of guidelines for the management of MaBC, and the rarity of this disease contribute to late diagnosis. The average delay
in diagnosis ranges from 6 to 10 months after the onset of symptoms, and about 40% are diagnosed in stages III and IV.
Clinical and radiological evaluation and tissue biopsy are essential for diagnosis. Screening should be initiated by evaluating risk factors, such as advanced age, radiation therapy, obesity, hormone imbalance, and BRCA2 mutations. The main
clinical finding is a single, retroareolar, and painless mass, usually in the left breast. It can involve axillary lymph nodes,
and, in rarer cases, nipple retraction, papillary discharge, and ulceration can be found. Mammography in men is generally more sensitive than in women. For biopsy, core biopsy is the preferred method. Conclusion: Despite its rarity, the
MaBC mortality rate is higher than women BC. That may be due to unawareness of the disease among patients and lack
of guidelines, possibly leading to medical negligence. Hence, careful attention to breast complaints, especially in highrisk patients, is mandatory to avoid late diagnosis. Promoting public awareness about MaBC and its symptoms is also
required. Furthermore, the development of guidelines for diagnostic purposes would improve the management of MaBC.

Downloads

Download data is not yet available.

Downloads

Published

2026-03-12

How to Cite

Ribeiro, L. A., Camargo, J. V. M. de, Galli, A. P., Resende, G. S., Santos, D. R. D., & Aranha, C. E. N. (2026). Male breast cancer: How to optimize the diagnosis?. Mastology, 33(suppl.1). https://doi.org/10.29289/259453942023V33S1077

Issue

Section

E-poster